Diabetes will be ‘a defining disease of this century’ as global cases are set to surpass one billion by 2050
The number of people with diabetes worldwide is set to more than double to 1.3…
Category: Life Sciences
STAT+: FDA rejects Intercept’s NASH drug, prompting a pivot
The Food and Drug Administration rejected Intercept Pharmaceuticals’ investigational treatment for NASH on Thursday, derailing…
CMS proposes new pathway for reimbursing breakthrough devices
Medical device makers may soon have an easier path to securing health insurance reimbursement for…
STAT+: Congress explores changes to the way Medicare pays doctors
Congress is taking early steps towards changing the way Medicare pays physicians. At a hearing…
The best AI opportunities, tech to improve 988, and an MRI fundraise
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Opinion: The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope
When I was diagnosed with Duchenne muscular dystrophy 20 years ago, there was no hope….
STAT+: Medicare puts out new details for covering the Alzheimer’s drug Leqembi, as the health system readies for potential approval
WASHINGTON — The health care system is on the precipice of broad access to a treatment…
.jpg)
Listen: Messy PBM conflicts, debatable vaccines, & the future of flu season
Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally…
FDA grants conditional approval to Sarepta’s gene therapy for Duchenne muscular dystrophy
The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for…
STAT+: The strategy behind the pharmaceutical industry’s flurry of lawsuits challenging drug pricing reform
WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere….
FDA moves to stop vape shops from selling Elf Bar, Esco Bars
WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape…
.jpg)
A looming penicillin shortage threatens pregnant adults with syphilis and their newborns
Pfizer announced last week that it expects to run out of a key drug for…
STAT+: Pharmalittle: Europe regulator raised safety signal on Novo drugs; U.S. seeks new trial over royalties on Gilead HIV prevention pills
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: U.S. seeks a new trial over royalties on Gilead HIV prevention pills
The U.S. government asked a federal judge to overturn a recent case in which a…
A 988 operator, faced with a flood of calls, turns to AI to boost counselor skills
Over 1,000 times a day, distressed people call crisis support lines operated by Protocall Services….
House GOP inquiry over gain-of-function research targets a scientific giant
For more than half a century, scientist Bernard Moss has been commanding the attention of…
Opinion: Former Surgeon General Jerome Adams: Prioritize new antivirals for Covid
The U.S. Covid-19 Public Health Emergency declaration may have ended, but the virus remains. Now is…
STAT+: Doctors’ lobby doubles down on the fight against expanding open access to research
Doctors’ lobbyists in Washington tend to focus their energies on ensuring Medicare pays well, and…
Alternative treatment options to relieve cancer symptoms – Beaufort … – The Island News
Alternative treatment options to relieve cancer symptoms – Beaufort … The Island News Read Original Article:…
CDC advisory panel recommends seniors ‘may’ get RSV vaccine
A panel of experts that advises the Centers for Disease Control and Prevention on vaccinations opted…
STAT+: European companies outline opposition to proposed overhaul of pharma policy
BRUSSELS — Leaders of European pharmaceutical companies on Wednesday said that a proposed overhaul of…
STAT+: Drug middlemen catch flak at another congressional hearing
Drug middlemen once again were on the hot seat at a congressional hearing on Wednesday….
Sen. Grassley calls on GOP leaders to rally support for PBM reforms
WASHINGTON — Republican Sen. Chuck Grassley wants to see his party’s leadership turn up the…
New DNA test aims to make cervical cancer screening more accessible in low-income countries
A genomic test for the human papillomavirus has shown promise in early-stage trials, raising hopes…
STAT+: PhRMA sues Biden administration over Medicare drug price negotiation program
WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle…
STAT Virtual Event: The Next Frontier of Drug Pricing Reform
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Novo Nordisk sues spas, clinics over compounded Wegovy; top lobbyist leaves PhRMA
Hello, everyone, and how are you this fine, sunny morning? The middle of the week…
STAT+: After promising early data, gene therapy trial for Huntington’s takes puzzling turn
Last year, after a string of high-profile trial failures, the Huntington’s disease community got positive…
STAT+: One of biotech’s biggest financiers launches small-molecule startup, in spite of IRA’s looming shadow
It’s been nearly a year since Congress passed the Inflation Reduction Act, raising a chorus…
Amid the AI gold rush, a new company forms to vet models and root out weaknesses
The market for artificial intelligence in health care is about as transparent as a brick…
‘I’m Not Crazy, I’m Sick’: A film dives deep into chronic Lyme disease
Elle Brooks-Tao, a filmmaker, got thrust into the confusing world of Lyme disease when a…
Scientists successfully unfroze rat organs and transplanted them — a ‘historic’ step that could someday transform transplant medicine
The rat kidney was peculiarly beautiful — an edgeless viscera about the size of a…
Opinion: Listen: How to save PrEP access — and even expand it
Under the Affordable Care Act, health insurers are required to cover all costs associated with…
Opinion: Pregnancy-related death, like Tori Bowie’s, is a far too common occurrence among Black women
The horror stories of Black women dying or coming close to death in childbirth never…
Xylazine, or ‘tranq,’ is making opioid overdoses harder to reverse
For years, public health guidance about opioid overdoses has been relatively simple: Administer naloxone, then…
Case Of Fake Brazilian Doctor Sparks Outrage — But Is “Alternative … – Worldcrunch
Case Of Fake Brazilian Doctor Sparks Outrage — But Is “Alternative … Worldcrunch Read Original Article:…
Alternative Therapies: Types, Uses And More – Forbes Health – Forbes
Alternative Therapies: Types, Uses And More – Forbes Health Forbes Read Original Article: Alternative Therapies: Types,…
TerrAscend Receives Regulatory Approval for Acquisition of … – Cannabis Business Times
TerrAscend Receives Regulatory Approval for Acquisition of … Cannabis Business Times Read Original Article: TerrAscend Receives…
STAT+: Top federal lobbyist at PhRMA leaves
WASHINGTON — The top federal lobbyist for the brand drug lobby PhRMA is leaving, two…
STAT+: Exact Sciences touts accuracy of updated Cologuard cancer test, but experts want more data
An updated version of Exact Sciences’ stool-based colorectal cancer screening test detected cancer accurately in…
STAT+: Novo Nordisk sues spas and clinics for selling versions of Wegovy and Ozempic for weight loss
In the latest fracas over obesity drugs, Novo Nordisk filed lawsuits alleging several medical spas,…
Government panel spurns calls for broader suicide risk screening
A panel of government advisers is sticking with its recommendation that providers screen most adults…
STAT+: Pharmalittle: Opaque conflicts permeate prescription drug benefits; Sanofi prevails in Zantac arbitration
Rise and shine, everyone, another busy day is on the way. We can tell by…
STAT+: Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal
Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an…
STAT+: ‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
Employers across the country — from big names like Boeing and UPS to local school…
STAT+: How drug pricing reforms are affecting Bayer’s investments
WASHINGTON — Pharma companies have long been warning Democrats’ drug pricing reforms could discourage investment in…
Opinion: Bloated patient records are filled with false information, thanks to copy-paste
I recently took care of a patient whose medical records included multiple notes about her…
STAT+: The FDA is testing new nutrition labels on the front of food packages
WASHINGTON — The FDA wants to make it easier for consumers to know if the…
TerrAscend’s $22M Purchase Of Peninsula Alternative Health Approved By Maryland’s Cannabis Admin – TerrAs – Benzinga
TerrAscend’s $22M Purchase Of Peninsula Alternative Health Approved By Maryland’s Cannabis Admin – TerrAs Benzinga Read…
TerrAscend’s US$22 Million Purchase of Peninsula Alternative Health Approved by the Maryland Cannabis Administration – Marketscreener.com
TerrAscend’s US$22 Million Purchase of Peninsula Alternative Health Approved by the Maryland Cannabis Administration Marketscreener.com Read…